![Dong-Hyun Yoon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 31/05/2026
Dong-Hyun Yoon currently works at Immuneoncia Therapeutics, Inc., as CFO, Director & Head-Management Planning from 2023.
Mr. Yoon also formerly worked at Green Cross Medical Science Corp., as Director, Managing Director & Head-Management.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNEONCIA THERAPEUTICS, INC. | Directeur Financier/CFO | 26/12/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| GC MEDICAL SCIENCE CORPORATION | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Green Cross Medical Science Corp.
 Green Cross Medical Science Corp. Medical SpecialtiesHealth Technology Engages in the manufacture and sale of in vitro diagnostic reagent products, medical equipment, and other medical supplies | Health Technology |
Immuneoncia Therapeutics, Inc.
 Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
